Skip to content

Clinical trials

Phase 1/2 Vascular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vascular Diseases Phase: Phase 1/2 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20091
20101
20113
20171
20201
20211
20221
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Active, not recruiting2
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
4D Molecular Therapeutics2
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)1
Atavistik Bio, Inc1
C. R. Bard1
Foundation for Biomedical Research and Innovation1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Retina Consultants of Hawaii1
Shenzhen University General Hospital1
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan1
UMC Utrecht1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vascular Diseases14
Cardiovascular Diseases8
Hemorrhagic Disorders3
Hemostatic Disorders3
Blood Protein Disorders2
Central Nervous System Diseases2
Cerebral Small Vessel Diseases2
Cerebrovascular Disorders2
Fabry Disease2
Genetic Diseases, Inborn2

Trials

Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.